Cigna Group $CI Shares Bought by Praxis Investment Management Inc.

Praxis Investment Management Inc. increased its holdings in Cigna Group (NYSE:CI) by 40.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,053 shares of the health services provider’s stock after purchasing an additional 2,019 shares during the quarter. Praxis Investment Management Inc.’s holdings in Cigna Group were worth $1,881,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CI. Norges Bank acquired a new stake in shares of Cigna Group during the 4th quarter valued at $1,019,790,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Cigna Group by 13,333.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after purchasing an additional 3,141,844 shares during the period. Capital Research Global Investors lifted its holdings in shares of Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after purchasing an additional 1,855,897 shares during the last quarter. Dodge & Cox lifted its holdings in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after purchasing an additional 1,833,389 shares during the last quarter. Finally, Boston Partners boosted its position in shares of Cigna Group by 314.6% in the 4th quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock valued at $450,856,000 after purchasing an additional 1,243,056 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Trading Down 0.1%

NYSE:CI opened at $287.50 on Friday. The stock has a market cap of $76.05 billion, a PE ratio of 12.19, a price-to-earnings-growth ratio of 1.11 and a beta of 0.29. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $323.10. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The stock’s 50-day moving average is $285.09 and its two-hundred day moving average is $279.24.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were given a $1.56 dividend. The ex-dividend date was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is presently 26.45%.

Analysts Set New Price Targets

Several analysts have issued reports on CI shares. Wells Fargo & Company boosted their price objective on Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. UBS Group raised their target price on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Sanford C. Bernstein boosted their price target on shares of Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a report on Tuesday, May 5th. Finally, Royal Bank Of Canada upped their price target on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.30.

Insiders Place Their Bets

In related news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.